[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
[ Fri, Jan 05th 2024 ]: WOPRAI
Kristen Kluska Initiated (CAPR) at Buy and Held Target at $8 on, Jan 5th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Kristen Kluska of Cantor Fitzgerald, Initiated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $8 on, Jan 5th, 2024.
Kristen has made no other calls on CAPR in the last 4 months.
There is 1 other peer that has a rating on CAPR. Out of the 1 peers that are also analyzing CAPR, 0 agree with Kristen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kristen
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Wednesday, October 4th, 2023